GO:0019766 IgA receptor activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0019766 IgA receptor activity is a molecular function defined as combining with an immunoglobulin of the IgA isotype via the Fc region and transmitting a signal across the membrane to initiate a change in cell activity.
The best-characterized IgA receptor is Fc alpha receptor I (FcalphaRI/CD89), which binds the Fc portion of IgA and triggers activating or inhibitory signaling depending on its associated adaptor proteins.
IgA receptor activity is central to mucosal immunity, immune complex clearance, and the pathogenesis of IgA nephropathy and inflammatory bowel disease.
Pathogenic bacteria have evolved IgA-specific proteins that subvert IgA receptor function, highlighting its importance in host-microbe interactions.
Pentraxins and other innate immune molecules modulate Fc receptor-mediated responses, including IgA receptor signaling.
CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of IgA receptor genes in disease.

Description

IgA receptor activity (GO:0019766) is a molecular function that enables a cell to bind immunoglobulin A (IgA) through its Fc region and convert that binding event into an intracellular signal. This activity is fundamental to mucosal immunity, where IgA is the predominant antibody isotype, and to systemic clearance of IgA-containing immune complexes. The receptor acts as a molecular bridge between the extracellular IgA pool and intracellular signaling cascades, thereby influencing inflammation, immune cell activation, and tissue homeostasis. Researchers study IgA receptor activity because dysregulation of this function is directly linked to common human diseases, including IgA nephropathy and ulcerative colitis. Moreover, pathogenic bacteria target IgA receptors to evade host defenses, making this activity a focal point for infection biology. Understanding the precise molecular mechanisms, the genes involved, and the experimental models available is therefore critical for both basic immunology and translational medicine.

IgA receptor activity At A Glance

GO ID GO:0019766
GO term IgA receptor activity
Ontology molecular_function
Synonym None listed in QuickGO
Major function Binding IgA via the Fc region and transmitting a signal across the membrane to initiate a change in cell activity
Major receptor Fc alpha receptor I (FcalphaRI/CD89) is the prototypical IgA receptor
Signaling outcome Can be activating or inhibitory depending on associated adaptor proteins and cellular context
Disease relevance IgA nephropathy, ulcerative colitis, and bacterial immune evasion
Modulation Regulated by pentraxins and other innate immune molecules

What Is GO:0019766?

According to the Gene Ontology, IgA receptor activity (GO:0019766) is defined as combining with an immunoglobulin of an IgA isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. In other words, it is the function of a cell-surface or soluble receptor that specifically recognizes the Fc portion of IgA and, upon binding, triggers a signaling event inside the cell. This activity is distinct from antigen recognition by the IgA variable region; it depends on the constant Fc domain and is therefore isotype-specific.

Why Is IgA receptor activity Important in Cell Biology?

IgA receptor activity is important because it governs how the immune system interprets the presence of IgA, the most abundant antibody at mucosal surfaces. This function determines whether IgA triggers a pro-inflammatory response, an anti-inflammatory response, or immune complex clearance. Dysregulation of IgA receptor activity contributes to the pathogenesis of IgA nephropathy, the most common primary glomerulonephritis worldwide, and to inflammatory bowel diseases such as ulcerative colitis. Additionally, many pathogenic bacteria produce IgA-specific proteins that interfere with IgA receptor function, underscoring its role in host-pathogen interactions. Studying this activity therefore provides insights into mucosal immunity, autoimmunity, and infectious disease.
IgA receptor activity is essential for mucosal immune defense and homeostasis.
It mediates the clearance of IgA-containing immune complexes from the circulation.
Dysregulated IgA receptor signaling is a key driver of IgA nephropathy.
IgA-coated bacterial vesicles in ulcerative colitis promote inflammation via IgA receptor interactions.
Pathogenic bacteria secrete IgA-specific proteins that subvert IgA receptor function.
The receptor can switch between activating and inhibitory functions, influencing immune cell fate.
Pentraxins modulate Fc receptor-mediated responses, including IgA receptor activity.
It is a target for therapeutic intervention in autoimmune and inflammatory diseases.
Understanding IgA receptor activity informs vaccine design for mucosal pathogens.
CRISPR models of IgA receptor genes enable causal studies of disease mechanisms.

Molecular Mechanism of IgA receptor activity

IgA Binding and Receptor Engagement
In simple terms: The receptor grabs IgA by its tail (Fc region).
The first step in IgA receptor activity is the specific binding of the receptor to the Fc region of IgA. This interaction is isotype-specific and does not occur with IgG or IgM. The prototypical receptor, FcalphaRI (CD89), binds both monomeric and polymeric IgA, although polymeric IgA and immune complexes are more efficient at triggering signaling. The binding affinity and stoichiometry determine the strength and duration of the subsequent signal.
Signal Transduction Across the Membrane
In simple terms: Binding causes a message to be sent inside the cell.
Upon IgA binding, the receptor undergoes conformational changes that lead to the phosphorylation of associated adaptor proteins, such as the Fc receptor gamma chain. This phosphorylation creates docking sites for signaling molecules that propagate the signal from the membrane to the cytoplasm. The outcome can be either activating or inhibitory, depending on the cellular context and the specific adaptor proteins recruited.
Activating versus Inhibitory Signaling
In simple terms: The receptor can either start or stop an immune response.
FcalphaRI is a molecular switch that determines whether IgA exerts activating or inhibitory functions. In the presence of certain adaptor proteins, the receptor triggers activating pathways such as calcium mobilization and cytokine production. In contrast, under different conditions, it can deliver inhibitory signals that dampen immune responses. This dual capacity is critical for maintaining immune balance in mucosal tissues.
Modulation by Pentraxins and Innate Immune Molecules
In simple terms: Other immune proteins can adjust the receptor's activity.
Pentraxins, such as C-reactive protein and serum amyloid P component, interact with Fc receptors and modulate their signaling. These interactions can enhance or suppress IgA receptor activity, thereby fine-tuning the immune response. This crosstalk between innate and adaptive immunity highlights the complexity of IgA receptor regulation.
Bacterial Subversion of IgA Receptor Activity
In simple terms: Some bacteria make proteins that block the receptor.
Pathogenic bacteria have evolved IgA-specific proteins that bind to IgA or to the receptor itself, interfering with IgA receptor activity. These proteins can prevent immune complex clearance or alter signaling to favor bacterial survival. This subversion is a key virulence mechanism in mucosal infections.

Key Genes Involved in GO:0019766 IgA receptor activity

The following genes and proteins are central to IgA receptor activity, as supported by published literature.
GeneMajor RoleResearch Relevance
FCAR (CD89)Encodes the prototypical IgA Fc receptor FcalphaRIMain receptor for IgA binding and signaling
FCER1GEncodes the Fc receptor gamma chain adaptorMediates signal transduction from FcalphaRI
PIGRPolymeric immunoglobulin receptorTransports IgA across epithelia, indirectly affecting receptor activity
CRPC-reactive protein, a pentraxinModulates Fc receptor-mediated responses
APCSSerum amyloid P component, a pentraxinModulates Fc receptor-mediated responses
C1GALT1GlycosyltransferaseAberrant IgA glycosylation in IgA nephropathy affects receptor binding
C1GALT1C1Chaperone for C1GALT1Required for normal IgA glycosylation
TLR4Toll-like receptor 4Innate immune sensor that can crosstalk with IgA receptor signaling
NLRP3Inflammasome sensorMay be activated downstream of IgA receptor signaling
IL6Interleukin-6Cytokine induced by IgA receptor activation
TNFTumor necrosis factorCytokine induced by IgA receptor activation
ITAMImmunoreceptor tyrosine-based activation motifSignaling motif in adaptors for FcalphaRI
ITIMImmunoreceptor tyrosine-based inhibitory motifSignaling motif that can mediate inhibitory signals
SYKSpleen tyrosine kinaseKinase activated downstream of FcalphaRI
PIK3CDPhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit deltaMay be involved in IgA receptor signaling
PLCG1Phospholipase C gamma 1Mediates calcium signaling downstream of FcalphaRI
PRKCBProtein kinase C betaDownstream effector of IgA receptor signaling

How Is IgA receptor activity Regulated?

IgA receptor activity is regulated at multiple levels. The expression of FCAR (CD89) is controlled by transcription factors and cytokines that influence myeloid cell differentiation. Post-translational modifications, including phosphorylation of the receptor-associated gamma chain, are essential for signal initiation. Pentraxins such as CRP and APCS can modulate the activity of Fc receptors, including IgA receptors, by binding to ligands or receptors. Additionally, the glycosylation state of IgA itself affects its affinity for the receptor; aberrant glycosylation, as seen in IgA nephropathy, alters receptor engagement and downstream signaling. Bacterial IgA-specific proteins can also regulate receptor activity by competing with or blocking IgA binding.

IgA receptor activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
FCARIgA nephropathyFCAR knockout mouse or human cell line
FCARUlcerative colitisFCAR knockout intestinal epithelial cells
C1GALT1IgA nephropathyC1GALT1 knockout cell line to study IgA glycosylation
FCER1GInflammatory signalingFCER1G knockout macrophages
PIGRMucosal immunityPIGR knockout epithelial cells
IgA Nephropathy
IgA nephropathy is characterized by the deposition of IgA-containing immune complexes in the glomeruli, leading to inflammation and kidney damage. The gut-renal connection in IgA nephropathy involves mucosal IgA production and its interaction with IgA receptors. Dysregulated IgA receptor activity on mesangial cells contributes to the activation of inflammatory pathways and mesangial proliferation. Understanding the molecular details of IgA receptor activity is therefore critical for developing targeted therapies.
Ulcerative Colitis and Inflammatory Bowel Disease
In ulcerative colitis, IgA-coated bacterial vesicles are enriched and drive inflammation. These vesicles interact with IgA receptors on immune cells, triggering pro-inflammatory signaling. This highlights the role of IgA receptor activity in the pathogenesis of inflammatory bowel diseases. Targeting this interaction may offer new therapeutic avenues.
Bacterial Infections and Immune Evasion
Pathogenic bacteria produce IgA-specific proteins that interfere with IgA receptor activity, allowing them to evade host immunity. These proteins can block IgA binding to receptors or alter downstream signaling. This immune evasion strategy is a key virulence mechanism in mucosal pathogens.

From IgA receptor activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does FCAR mediate IgA-induced signaling?FCAR knockout cell line (e.g., THP-1)
What is the role of FCER1G in IgA receptor signaling?FCER1G point-mutation knock-in mice
How does IgA glycosylation affect receptor binding?C1GALT1 knockout cells
Can IgA receptor activity be monitored in live cells?Tagged knock-in of FCAR with fluorescent protein
Does overexpression of FCAR enhance IgA responses?FCAR overexpression in myeloid cells
What genes modulate IgA receptor signaling?CRISPR library screening in IgA-stimulated cells

How to Study the IgA receptor activity Process

MethodWhat It MeasuresTypical Application
CRISPR knockout screeningGenes required for IgA receptor signalingIdentify novel regulators
PhosphoproteomicsPhosphorylation events downstream of receptorMap signaling pathways
Flow cytometryIgA binding and receptor expressionQuantify receptor levels
Confocal microscopyReceptor localization and internalizationStudy trafficking
ELISACytokine secretionMeasure functional outcomes
Western blotProtein expression and phosphorylationValidate signaling changes
qPCRmRNA levels of receptor and cytokinesAssess transcriptional responses
CRISPR knock-inTagged receptor for live imagingTrack receptor dynamics
CRISPR-Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that regulate IgA receptor activity. Cells are transduced with a lentiviral sgRNA library, selected, and stimulated with IgA or IgA immune complexes. Enrichment or depletion of sgRNAs reveals candidate regulators. This approach has been used to uncover signaling components downstream of Fc receptors.
Phosphoproteomics
Phosphoproteomics can map the signaling cascades triggered by IgA receptor engagement. Cells are stimulated with IgA, and phosphopeptides are enriched and analyzed by mass spectrometry. This reveals phosphorylation events on the receptor and downstream effectors. Such studies have identified key kinases and adaptors in Fc receptor signaling.
Flow Cytometry and Imaging
Flow cytometry can measure IgA binding to cells and receptor internalization. Imaging techniques, such as confocal microscopy, can visualize the co-localization of IgA receptors with signaling molecules. These methods are useful for studying receptor trafficking and signaling dynamics.
Cytokine Profiling
Cytokine profiling by ELISA or multiplex assays measures the functional outcome of IgA receptor activation. Cells are stimulated with IgA, and supernatants are analyzed for cytokines such as IL-6 and TNF. This provides a readout of activating versus inhibitory signaling.

How CRISPR Can Be Used to Study GO:0019766 IgA receptor activity

Knockout

CRISPR knockout of FCAR or FCER1G can abolish IgA receptor activity, providing a clean background to study its function. Knockout cell lines are generated by introducing frameshift mutations in early exons. These models are used to test whether a candidate gene is required for IgA-induced signaling.

Point Mutation

Point mutations can be introduced into FCAR or FCER1G to dissect specific signaling motifs, such as ITAM or ITIM tyrosines. For example, mutating the ITAM tyrosine in FCER1G prevents phosphorylation and downstream signaling. Such models are valuable for understanding the molecular switch between activating and inhibitory functions.

Knock-in

Knock-in of a fluorescent tag (e.g., GFP) into the endogenous FCAR locus allows real-time visualization of receptor expression and trafficking. This approach preserves endogenous regulatory elements and provides physiological expression levels. Tagged knock-in models are ideal for imaging studies.

Overexpression

Overexpression of FCAR in cell lines can enhance IgA receptor signaling and sensitize cells to IgA stimulation. This is useful for studying gain-of-function effects and for screening drugs that modulate receptor activity. Overexpression models can also reveal downstream pathways that are otherwise masked.

How EDITGENE Supports IgA receptor activity Research

Researchers studying IgA receptor activity-related genes often need to determine whether a candidate gene is causally involved in IgA binding, signaling, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0019766 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for IgA receptor activity research.

Frequently Asked Questions About IgA receptor activity

IgA receptor activity (GO:0019766) is a molecular function that combines with immunoglobulin A via its Fc region and transmits a signal across the membrane to initiate a change in cell activity.
Key genes include FCAR (CD89), FCER1G, PIGR, and C1GALT1, among others.
FCAR encodes FcalphaRI (CD89), the prototypical receptor that binds IgA and triggers intracellular signaling.
Dysregulated IgA receptor activity contributes to the deposition of IgA immune complexes in the kidney, driving inflammation and damage.
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect the function of IgA receptor genes.
IgA nephropathy, ulcerative colitis, and bacterial infections are associated with altered IgA receptor activity.
Pathogenic bacteria produce IgA-specific proteins that block IgA binding or interfere with receptor signaling.
FcalphaRI can switch between activating and inhibitory functions depending on associated adaptor proteins and cellular context.
Common methods include CRISPR screening, phosphoproteomics, flow cytometry, and cytokine profiling.
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for genes related to IgA receptor activity.

Conclusion

IgA receptor activity (GO:0019766) is a critical molecular function that bridges IgA recognition with intracellular signaling, influencing mucosal immunity and disease pathogenesis. Its dysregulation is implicated in IgA nephropathy, ulcerative colitis, and bacterial immune evasion. Understanding the underlying mechanisms and genes requires robust experimental models, and CRISPR-based approaches offer precise tools for functional dissection. EDITGENE's comprehensive services empower researchers to generate tailored cell models and accelerate discoveries in this field.

References

  1. 1. Monteiro RC et al.. 2003. IgA Fc receptors.. Annu Rev Immunol 21:177-204 PMID: 12524384
  2. 2. van Egmond M et al.. 2001. IgA and the IgA Fc receptor.. Trends Immunol 22(4):205-11 PMID: 11274926
  3. 3. Thapa HB et al.. 2025. Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation.. Nat Commun 16(1):3995 PMID: 40301356
  4. 5. Kazeeva TN et al.. 2009. IgA-specific proteins of pathogenic bacteria.. Biochemistry (Mosc) 74(1):12-21 PMID: 19232043
  5. 6. Coppo R. 2018. The Gut-Renal Connection in IgA Nephropathy.. Semin Nephrol 38(5):504-512 PMID: 30177022
  6. 7. Lu J et al.. 2018. Pentraxins and Fc Receptor-Mediated Immune Responses.. Front Immunol 9:2607 PMID: 30483265
  7. 8. Kanamaru Y et al.. 2007. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions.. Contrib Nephrol 157:148-52 PMID: 17495454
Contact Us
*
*
*
*
How did you hear about us: